Comparison of dosage of intensive upper limb therapy for children with unilateral cerebral palsy: how big should the therapy pill be?
Sixty hours of mitt therapy beats thirty for hand skills, yet thirty hours still lifts everyday independence.
01Research in Context
What this study did
Researchers split kids with unilateral cerebral palsy into two groups. One group got 60 hours of modified constraint therapy. The other got 30 hours.
Both groups wore a mitt on the strong hand and did fun tasks with the weak hand. Therapists measured how well kids used both hands together and how fast they could move small objects.
What they found
Kids who got the full 60 hours scored higher on bimanual games and finger dexterity tests. Kids who got 30 hours still showed real gains in daily tasks like dressing and eating.
More hours meant bigger motor changes, but half the dose still helped families see useful progress at home.
How this fits with other research
Wehman et al. (2014) ran a similar dose test with toddlers who had Down syndrome. They also saw that five sessions a week beat one session a week for vocabulary growth. Both studies say the same thing: more practice time gives stronger skills.
Soloveichick et al. (2020) worked with tiny preterm babies at risk for cerebral palsy. Their gentle movement imitation also led to normal toddler development. Together, the three papers show that early, frequent motor practice helps across ages and methods.
Barton et al. (2019) looked inside the brain with fMRI and found typical mirror-neuron activity in kids with motor delays. Their null result reminds us that behavior gains may come from practice, not from fixing broken brain circuits.
Why it matters
If you only have funding for 30 hours, you can still make a real difference in daily life. When you can get 60 hours, push for it—kids will gain finer finger skills and smoother two-hand play. Share the dose chart with families and payers so they know both choices work, but more is better.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Count the hours on your current mCIMT plan—if it’s under 30, add sessions; if it’s near 30, aim for 60 when insurance allows.
02At a glance
03Original abstract
This study aimed to compare efficacy of two dosages of modified constraint induced movement therapy (mCIMT) and bimanual therapy on upper limb and individualized outcomes for children with unilateral cerebral palsy. This secondary analysis included two separate randomized trials that compared equal doses (high or low) of mCIMT to bimanual therapy; Study 1 (full dose--60 h) n=64 and; Study 2 (half dose--30 h) n=18 for children aged five to 16 years with unilateral cerebral palsy. Outcomes for both studies included the Melbourne Assessment of Unilateral Upper Limb Function, Assisting Hand Assessment, Jebsen Taylor Test of Hand Function and Canadian Occupational Performance Measure which were administered at baseline, three and 26 weeks. Mixed linear modelling was used to compare between dose (e.g. "full dose" to "half dose" of either mCIMT or bimanual therapy) on outcomes at three and 26 weeks post-intervention. There were no significant differences between groups at baseline, however, on average the half dose mCIMT group was younger with better hand function compared to the other groups. The full compared to half dose mCIMT group achieved greater gains in bimanual performance at three weeks and dexterity and quality of movement at 26 weeks. There were no between group differences for bimanual therapy doses. Half dose groups receiving either mCIMT or bimanual therapy did not make significant within group gains on any upper limb motor outcome, however gains in occupational performance were clinically meaningful. These results suggest that a half dose (30 h) of either mCIMT or bimanual therapy may not be sufficient to impact upper limb outcomes, but made clinically meaningful gains in occupational performance for school aged children with UCP.
Research in developmental disabilities, 2015 · doi:10.1016/j.ridd.2014.10.050